If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 10 of 39
Enhancing Reading Recovery in Aphasia With tDCS and PMT
Objective
Enhancing Reading Recovery in Aphasia With tDCS and PMT
Protocol No
NEURO-IIT-PSB-RAT
Categories
A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692 and Ocrevus (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Objective
ABP692 v Ocrelizumab in Relapsing-Remitting MS
Protocol No
NEURO-AMGEN-20230309
An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis
Objective
Long-term Extension Study of ABC008 in Subjects with Inclusion Body Myositis
Protocol No
NEURO-ABCURO-ABC008-IBM-202
Neural Representation of Lexical Concepts - functional MRI
Objective
Neural Representation of Lexical Concepts - fMRI
Protocol No
NEURO-IIT-FERNANDINO-NEUROLEX
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Complications
Objective
CVN424 in Parkinson's Disease Participants With Motor Complications
Protocol No
NEURO-CEREVANCE-CVN424-301
Establishing an AI-based Foundation for Remote Automated Speech and Language Therapy in Aphasia
Objective
PIC NAME AI
Protocol No
NEURO-IIT-ANDERSON-PICNAMEAI
The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
Objective
Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment - EMAGINE 2.0
Protocol No
PMR-BRAINQ-EMAGINE-2
Categories
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)
Objective
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults
Protocol No
GIM-DUKE-PREVENTABLE
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
Objective
Registry of Patients with AQP4+ NMOSD Treated with Alexion C5 Inhibitor Therapies
Protocol No
NEURO-ALEXION-ALX-NMO-501
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (Nmdar) Or Anti-Leuci
Objective
Satralizumab in NMDAR or LGI1 Enchephalitis
Protocol No
NEURO-GENENTECH-CIELO